ASSESSMENT OF TIC DISORDERS USING THE YALE GLOBAL TIC SEVERITY SCALE (YSTSS) AMONG CHILDREN ATTENDING NATIONAL CHILDREN’S HOSPITAL IN 2025
Main Article Content
Abstract
Objectives: To describe the severity of tic disorders using the Yale Global Tic Severity Scale (YGTSS) and to examine factors associated with tic severity among children attending the National Children’s Hospital in 2025.
Subjects and methods: A cross-sectional descriptive study was conducted on 176 patients under 18 years of age diagnosed with tic disorders according to ICD-10 criteria. All participants had not received pharmacological or psychological treatment for tic disorders prior to enrollment. Tic severity was assessed using the YGTSS. Data were managed and analyzed using RStudio software.
Results: Boys accounted for 75% of the sample, with a male-to-female ratio of 3:1. The mean age at diagnosis was 6.60 ± 2.63 years. Most patients were diagnosed with transient tic disorder (72.2%). The mean Total Tic Severity Score was 16.34 ± 7.01, the mean impairment score was 16.64 ± 6.62, and the mean global YGTSS score was 30.0 ± 11.2. No significant difference in tic severity was found between sexes. Age at diagnosis and duration of illness were positively associated with tic severity. Children with comorbid conditions, particularly attention-deficit/hyperactivity disorder, autism spectrum disorder, had significantly higher YGTSS scores than those without comorbidities (p < 0.05).
Conclusions: Tic disorders in children present with varying degrees of severity and functional impairment. The YGTSS is a valuable tool for comprehensive assessment of tic severity and functional impact. A holistic approach to the evaluation and management of tic disorders, including early detection and assessment of comorbid conditions, is essential to reduce clinical burden and improve outcomes.
Article Details
Keywords
tic disorders, Tourette, YGTSS.
References
[2] Leckman JF, King RA, Bloch MH. Clinical Features of Tourette Syndrome and Tic Disorders. J Obsessive Compuls Relat Disord. 2014;3(4):372 - 379. DOI: 10.1016/j.jocrd.2014.03.004
[3] Zheng R yuan, Jin R, Xu H qin, et al. [Study on the prevalence of tic disorders in schoolchildren aged 7-16 years old in Wenzhou]. Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi. 2004;25(9):745-747. PMID: 15555352.
[4] Yang J, Hirsch L, Martino D, Jette N, Roberts J, Pringsheim T. The prevalence of diagnosed tourette syndrome in Canada: A national population-based study. Mov Disord Off J Mov Disord Soc. 2016;31(11):1658-1663. DOI: 10.1002/mds.26766
[5] Robertson MM, Eapen V, Cavanna AE. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. J Psychosom Res. 2009;67(6):475-483. DOI: 10.1016/j.jpsychores.2009.07.010
[6] Himle MB, Capriotti MR, Hayes LP, et al. Variables Associated With Tic Exacerbation in Children With Chronic Tic Disorders. Behav Modif. 2014;38(2):163-183.
[7] Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989 Jul;28(4):566-73. DOI: 10.1177/0145445514531016
[8] Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol. 2012 Aug;47(2):77-90. DOI: 10.1016/j.pediatrneurol.2012.05.002
[9] Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009;67(6):497-501. DOI: 10.1016/j.jpsychores.2009.09.002
[10] Jankovic J. PHENOMENOLOGY AND CLASSIFICATION OF TICS. Neurol Clin. 1997;15(2):267-275. DOI: 10.1016/s0733-8619(05)70311-x
[11] Cohen SC, Leckman JF, Bloch MH. Clinical assessment of Tourette syndrome and tic disorders. Neurosci Biobehav Rev. 2013 Jul;37(6):997-1007.
[12] Jung Y-W, Park T-W. Environmental Risk Factors in Tic Disorders. Korean Academy of Child and Adolescent Psychiatry; 2010. p. 133–40. DOI: 10.1016/j.neubiorev.2012.11.013
[13] Szejko N, Robinson S, Hartmann A, et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment. Eur Child Adolesc Psychiatry. 2022;31(3):383-402. DOI: 10.1007/s00787-021-01842-2
[14] Sambrani T, Jakubovski E, Müller-Vahl KR. New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center. Front Neurosci. 2016 Sep 12;10:415. DOI: 10.3389/fnins.2016.00415
[15] Richer F, Daghfal R, Rouleau GA, Lespérance P, Chouinard S. Clinical features associated with an early onset in chronic tic disorders. Psychiatry Res. 2015 Dec 30;230(3):745-8. DOI: 10.1016/j.psychres.2015.11.018
[16] Bloch MH, Peterson BS, Scahill L, et al. Meta-analysis of the treatment of ADHD in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009;48(9):884–893. DOI: 10.1097/CHI.0b013e3181b26e9f